Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1950 1
1951 2
1953 3
1954 1
1955 1
1956 1
1957 3
1958 5
1959 3
1960 3
1961 2
1962 2
1963 2
1964 2
1965 9
1966 3
1967 2
1968 1
1969 1
1970 2
1971 2
1972 1
1973 1
1975 1
1976 3
1977 2
1978 5
1979 2
1980 6
1981 1
1982 3
1983 4
1984 9
1985 4
1986 5
1987 3
1988 3
1989 3
1990 3
1992 1
1993 3
1994 5
1995 6
1996 3
1997 8
1998 11
1999 8
2000 9
2001 9
2002 5
2003 6
2004 9
2005 8
2006 6
2007 10
2008 16
2009 21
2010 22
2011 33
2012 35
2013 41
2014 26
2015 20
2016 19
2017 16
2018 18
2019 18
2020 23
2021 27
2022 33
2023 25
2024 20
2025 18

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

608 results

Results by year

Filters applied: . Clear all
Page 1
Intrinsic cell-penetrating activity propels Omomyc from proof of concept to viable anti-MYC therapy.
Beaulieu ME, Jauset T, Massó-Vallés D, Martínez-Martín S, Rahl P, Maltais L, Zacarias-Fluck MF, Casacuberta-Serra S, Serrano Del Pozo E, Fiore C, Foradada L, Cano VC, Sánchez-Hervás M, Guenther M, Romero Sanz E, Oteo M, Tremblay C, Martín G, Letourneau D, Montagne M, Morcillo Alonso MÁ, Whitfield JR, Lavigne P, Soucek L. Beaulieu ME, et al. Sci Transl Med. 2019 Mar 20;11(484):eaar5012. doi: 10.1126/scitranslmed.aar5012. Sci Transl Med. 2019. PMID: 30894502 Free PMC article.
Finding MYCure.
Beaulieu ME, Soucek L. Beaulieu ME, et al. Mol Cell Oncol. 2019 Jun 20;6(5):e1618178. doi: 10.1080/23723556.2019.1618178. eCollection 2019. Mol Cell Oncol. 2019. PMID: 31528695 Free PMC article.
MYC targeting by OMO-103 in solid tumors: a phase 1 trial.
Garralda E, Beaulieu ME, Moreno V, Casacuberta-Serra S, Martínez-Martín S, Foradada L, Alonso G, Massó-Vallés D, López-Estévez S, Jauset T, Corral de la Fuente E, Doger B, Hernández T, Perez-Lopez R, Arqués O, Castillo Cano V, Morales J, Whitfield JR, Niewel M, Soucek L, Calvo E. Garralda E, et al. Among authors: beaulieu me. Nat Med. 2024 Mar;30(3):762-771. doi: 10.1038/s41591-024-02805-1. Epub 2024 Feb 6. Nat Med. 2024. PMID: 38321218 Free PMC article. Clinical Trial.
Correction.
Luc M, Beaulieu MC, Breton M, Boulianne I, Champagne L, Conway S, Côté N, Deshaies JF, Fillion M, Villemure P, Hudon C. Luc M, et al. Among authors: beaulieu mc. Can Fam Physician. 2021 Apr;67(4):231. doi: 10.46747/cfp.6704231. Can Fam Physician. 2021. PMID: 33853906 Free PMC article. No abstract available.
EV20/Omomyc: A novel dual MYC/HER3 targeting immunoconjugate.
Bibbò S, Capone E, Lovato G, Ponziani S, Lamolinara A, Iezzi M, Lattanzio R, Mazzocco K, Morini M, Giansanti F, De Laurenzi V, Whitfield J, Iacobelli S, Ippoliti R, Beaulieu ME, Soucek L, Sala A, Sala G. Bibbò S, et al. Among authors: beaulieu me. J Control Release. 2024 Oct;374:171-180. doi: 10.1016/j.jconrel.2024.08.009. Epub 2024 Aug 14. J Control Release. 2024. PMID: 39128771 Free article.
608 results